+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Small Molecule Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pre Book Price: $ 5216

Original Price: $ 5795

Small molecule kinase inhibitors are a form of enzyme inhibitors and are mostly used for the treatment of cancer. Protein kinase aids in the development and progression of tumors and small molecule kinase inhibitors help in obstructing unregulated cell cycle. The growing incidence of cancer cases around the globe is one of the major factors that propel the small molecule kinase inhibitors market. This has driven pharma companies and regulatory bodies to further speed up the process of clinical trials and drug approvals. 
The research report analyzing the small molecule kinase inhibitors market studies the industrial landscape and presents a qualitative and quantitative portrait of the expected performance of the market from 2013 to 2019.
The data is derived from primary and secondary research, ensuring absolutely unbiased and authentic evaluation of the small molecule kinase inhibitors market. With the help of Porter’s five forces analysis, the report studies the role of buyers, suppliers, substitutes, new entrants, and competitors in the global market. Growth factors, challenges, and opportunities are identified and discussed at length and added emphasis is laid on government regulations that govern that pharmaceutical industry.    
Overview of the small molecule kinase inhibitors market 
The small molecule kinase inhibitors market is projected to witness robust growth in the coming years with rising popularity of the next generation of kinase inhibitor drugs, multi-targeted kinase inhibitors, and combination drug therapies. The use of kinase inhibitors for the treatment of various oncology and non-oncology diseases has grown, and while cancer end-use application areas are much stronger, non-cancer therapies are bound to gain interest.
Key kinase inhibitor drugs that have made a significant contribution to the global market include Sorafenib, Gefitinib, Iressa, Temsirolimus, Imatinib, Dasatinib, Rapamycin, Nilotinib, Everolimus, Sunitinib, Erlotinib, and Lapatinib. These commercially-available drugs are designed to target and treat specific diseases. There are numerous small molecule kinase inhibitor drugs in the pipeline, a factor that is anticipated to boost the global market. These pipeline drugs include Pazopanib, Cediranib, CP-690550, Bosutinib, Vandetanib, Alvocidib, Motesanib, and Ridaforolimus.
Despite the availability of a number of kinase inhibitors, the anticipated rise in cancer cases all over the world poses high potential for the growth of the small molecule kinase inhibitors market. However, strict regulatory riders, lengthy approval procedures, and mounting costs of next-generation cancer drugs are matters of concern that hamper the expansion of the small molecule kinase inhibitors market. 
Companies mentioned in the research report
Prominent names in the small molecule kinase inhibitors market include Bristol-Myers Squibb, Amgen, KAI Pharmaceuticals, Onyx Pharmaceuticals, Wyeth, OSI Pharmaceuticals, Glaxo SmithKline, Merck & Co, Pfizer, Bayer Schering Pharma, Roche, Sanofi-Aventis, AstraZeneca, Novartis, Genentech, and Celgene Corporation. The research study discusses these companies with respect to company overview, financial standing, product portfolio, recent developments in the small molecule kinase inhibitors market, mergers and acquisitions, business strategies, and SWOT analysis.
Major geographies analyzed under this research report are: 
  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top